• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Exploratory research of microRNA related to pre-metastatic lymph node niche formation in prostate cancer.

Research Project

Project/Area Number 18K07210
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Review Section Basic Section 50010:Tumor biology-related
Research InstitutionSaitama Medical University (2019-2021)
Aichi Medical University (2018)

Principal Investigator

Kanao Kent  埼玉医科大学, 医学部, 准教授 (20327620)

Co-Investigator(Kenkyū-buntansha) 都築 豊徳  愛知医科大学, 医学部, 教授 (70627645)
Project Period (FY) 2018-04-01 – 2022-03-31
Project Status Completed (Fiscal Year 2021)
Budget Amount *help
¥2,730,000 (Direct Cost: ¥2,100,000、Indirect Cost: ¥630,000)
Fiscal Year 2020: ¥390,000 (Direct Cost: ¥300,000、Indirect Cost: ¥90,000)
Fiscal Year 2019: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2018: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Keywords前転移ニッチ / エクソソーム / microRNA / リンパ節転移 / 前立腺癌
Outline of Final Research Achievements

Among patients who underwent total prostatectomy and lymph node dissection, patients with a Gleason score of 6 (Low risk group), patients with 9 or higher (High risk group), and patients with lymph node metastasis (N) (+) Group) resected lymph node FFPE sections were collected. The lymph node tissue of the section (in the N (+) group, the site without metastasis of the lymph node with metastasis) was macrodissection and miRNA-seq was performed. When the FDR value was set to <0.05 and the FDR value was set to Log2 <-0.5 or> 0.5, we found one miRNA between the High risk group and the N (+) group, and 7 miRNA between the High risk group and the N (+) group that showed significant differences in expression.

Academic Significance and Societal Importance of the Research Achievements

今回有意差を示したmiRNAについては、今後個別に定量PCRでもその差を明らかにしていく予定である。これらのmiRNAは本研究の目的であった、リンパ節の前転移ニッチ形成に関与するmiRNAの候補となる。今後の検証により、前転移ニッチ形成に対する感度、特異度が高いmiRNAであれば、リンパ節転移を起こす準備段階の前立腺癌を診断することが可能となり、前立腺生検検体や血中からのmiRNA抽出により監視療法の適応患者選択や、監視療法中に治療介入を行うかどうかを判断するバイオマーカーの一つに利用できると考えられる。

Report

(5 results)
  • 2021 Annual Research Report   Final Research Report ( PDF )
  • 2020 Research-status Report
  • 2019 Research-status Report
  • 2018 Research-status Report
  • Research Products

    (3 results)

All 2021 2019

All Journal Article (3 results) (of which Int'l Joint Research: 1 results,  Peer Reviewed: 3 results,  Open Access: 1 results)

  • [Journal Article] Safety of adjuvant gemcitabine plus cisplatin chemotherapy in a patient with bilateral ureteral cancer undergoing hemodialysis2021

    • Author(s)
      Goto Yumiko、Kanao Kent、Matsumoto Kazuhiro、Kobayashi Ikuo、Kajikawa Keishi、Onishi Masafumi
    • Journal Title

      International Cancer Conference Journal

      Volume: 10 Issue: 3 Pages: 212-216

    • DOI

      10.1007/s13691-021-00483-1

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Increased infiltration of CCR4-positive regulatory T cells in prostate cancer tissue is associated with a poor prognosis.2019

    • Author(s)
      Watanabe M, Kanao K, Suzuki S, Muramatsu H, Morinaga S, Kajikawa K, Kobayashi I, Nishikawa G, Kato Y, Zennami K, Nakamura K, Tsuzuki T, Yoshikawa K, Ueda R, Sumitomo M.
    • Journal Title

      Prostate

      Volume: 79(14) Issue: 14 Pages: 1658-1665

    • DOI

      10.1002/pros.23890

    • Related Report
      2019 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Prostate-specific Antigen Response Patterns During Cabazitaxel Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer2019

    • Author(s)
      Kent Kanao, Toshiki Ito, Kiyoshi Takahara, Ryosuke Ando, Takahiro Yasui, Ryoichi Shiroki, Hideaki Miyake, Makoto Sumitomo
    • Journal Title

      Jpn J Clin Oncol

      Volume: 49 Issue: 11 Pages: 1043-1048

    • DOI

      10.1093/jjco/hyz110

    • Related Report
      2019 Research-status Report
    • Peer Reviewed

URL: 

Published: 2018-04-23   Modified: 2023-01-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi